Skip to main content
A

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Filings indexed 1,284 across all filing types
Latest filing 2023-09-21 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
安图生物关于控股股东自愿承诺不减持公司股份的公告
Regulatory Filings
2023-09-21 Chinese
安图生物关于召开2023年半年度业绩说明会的公告
Regulatory Filings
2023-09-01 Chinese
安图生物关于公司及子公司获得医疗器械注册证的公告
Regulatory Filings
2023-08-30 Chinese
安图生物持股5%以上股东减持股份结果公告
Regulatory Filings
2023-08-21 Chinese
安图生物第四届监事会第十次会议决议公告
Regulatory Filings
2023-08-17 Chinese
安图生物第四届董事会第十一次会议决议公告
Regulatory Filings
2023-08-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.